South Asians have a higher prevalence of diabetes, coronary heart disease and cardiovascular death. Their predisposition to insulin resistance partly explains this excess risk. After immigration, the adoption of a western diet allied to increased sedentary behaviour leads to weight gain, hypertension and hyperlipidaemia, factors which in turn combine to amplify the chances of getting heart disease. Further contributory factors are increased sub-clinical inflammation, increased thrombogenic tendency and higher serum homocysteine levels. South Asians with diabetes might do as well as White people with respect to intensive glycaemic and blood pressure control. However, there is little evidence for measures to reduce cardiovascular risk as South Asians have not been included as a subgroup in most large trials. Future prospective studies, including studies on the prevention of diabetes and cardiovascular disease in this high-risk population, are therefore urgently required.
Mather H., Keen H.The Southall Diabetes survey: prevalence of known diabetes in Asians and Europeans . BMJ (Clin Res Ed)1985;291:1081-4.
2.
Samanta A., Burden AC, Fent B.Comparative prevalence of non-insulin dependant diabetes mellitus in Asian and white Caucasian adults. Diabetes Res Clin Pract1987;4:1-6.
3.
Ramachandran A., Snehalata C., Kapur A. et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia2001;44:1094-101.
4.
Gupta R., Gupta VPMeta-analysis of coronary heart disease prevalence in India. Indian Heart J1996;48:241-5.
5.
Wild S., McKeigue P.Cross-sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ1997;314:705-10.
6.
Sheth T., Nair C., Nargundkar M., Anand S., Yusuf S.Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths . CMAJ1999;161:132-8.
7.
McKeigue PM, Ferrie JE, Marmot MGAssociation of early-onset Coronary Heart Disease in south Asian men with glucose intolerance and hyperinsulinaemia. Circulation1993;87:152-61.
8.
Mather HM, Chaturvedi N., Fuller JHMortality and morbidity from diabetes in south Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med1998;15:53-9.
9.
UK Prospective Diabetes Study Group.The incidence of myocardial infarction in White, south Asian and Afro-Caribbean patients with type 2 diabetes (UKPDS 32). Diabetes Care1998;21:1271-7.
10.
Davis TME , Cull CA, Holman RR for the UKPDS group.Relationship between ethnicity and glycaemic control, lipid profiles and blood pressure during the first 9 years of type 2 diabetes. Diabetes Care2001; 24:1167-74.
11.
UK Prospective Diabetes Study Group.UK Prospective Diabetes Study XII: Differences between Asian, AfroCaribbean and White Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabet Med1994;11:670-7.
12.
Wilkinson P. , Sayer J., Koorithottumkal L. et al. Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study. BMJ1996;312:1330-3.
13.
Bhopal R., Unwin N., White M. et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi and European origin populations: cross sectional study . BMJ1999;319:215-20.
14.
Yusuf S., Hawken S., Ounpuu S., Dans T. et al. on behalf of INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet2004;364:937-52.
15.
Sniderman AD , Furberg CD, Keech A. et al. Apoproteins versus lipids as indices of coronary risk and as targets for statin therapy: analysis of the evidence . Lancet2003;36:777-80.
16.
Williams K. , Sniderman AD, Sattar N., D'Agostino R. Jr, Wagenknecht LE, Haffner SMComparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation2003;108:2312-16.
17.
Bhatnagar D. , Anand IS, Durrington PN et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India . Lancet1995;345:405-09.
18.
McKeigue PM , Shah B., Marmot MGRelation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in south Asians. Lancet1991;337:382-6.
19.
Pan CY, So WY, Khalid BAK et al. on behalf of the ASDIAB Study Group.Metabolic, immunological and clinical characteristics in newly diagnosed Asian diabetes patients aged 12-40 years. Diabet Med2004;21:1007-13.
20.
Whincup PH, Gilg JA, Papacosta O. et al. Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ2002;324:635-8.
21.
Yajnik CS, Lubree HG, Rege SS et al. Adiposity and hyperinsulinaemia in Indians are present at birth . J Clin Endocrinol Metab2002;87:5575-80.
22.
Lydakis C., Lip G.Microalbuminuria and cardiovascular risk. QJM1998;91: 381-91.
23.
Fischbacher CM , Bhopal R., Rutter MK et al. Microalbuminuria is more frequent in south Asian than in European origin populations: a comparative study in Newcastle UK. Diabet Med2003;20:31-6.
24.
Anand SS, Yusuf S., Vuksan V. et al. for the SHARE investigators.Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups. Lancet2000;356:279-84.
25.
Festa A., D'gostino R. Jr, Tracy RP, Haffner SMElevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes2002;51:1131-7.
26.
Kain K., Catto AJ, Grant PJImpaired fibrinolysis and increased fibrinogen levels in south Asian subjects . Atherosclerosis2001;156:457-61.
27.
Kain K., Catto AJ, Grant PJAssociations between insulin resistance and thrombotic risk factors in high-risk south Asian subjects. Diabet Med2003;20:651-5.
28.
Forouhi NG, Rumley A., Lowe GD, McKeigue P., Sattar N.Specific elevation in plasma tissue plasminogen activator antigen concentrations in South Asians relative to Europeans. Blood Coagul Fibrinolysis2003;14: 755-60.
29.
Eliasson MC , Jansson JH, Lindahl B., Stegmayr B.High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MON-ICA Study. Cardiovasc Diabetol2003;2:19.
30.
Lowe GD, Danesh J., Lewington S. et al. Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J2004;25:252-9.
31.
Velmurugan K., Deepa R., Ravikumar R. et al. Relationship of lipoprotein(a) with intimal medial thickness of the carotid artery in type 2 diabetic patients in south India. Diabet Med2003;20:455-61.
32.
Danesh J., Collins R., Peto R.Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies . Circulation2000;102:1082-5.
33.
Lindsay RS, Funahashi T., Matsuzawa Y. et al. Adiponectin Protects Against Development of Type 2 Diabetes in the Pima Indian Population. Lancet2002 ;360:57-8.
34.
Pischon T., Girman CJ, Hotamisligil GS, Rifai N., Hu FB, Rimm EBPlasma adiponectin levels and risk of myocardial infarction in men. JAMA2004;291:1730-7.
35.
Zoccali C., Mallamaci F., Tripepi G. et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol2002;13:134-41.
36.
Retnakaran R., Hanley AJG, Raif N., Connelly PW, Sermer M., Zinman B.Hypoadiponectinaemia in south Asian women during pregnancy: evidence of ethnic variation in adiponectin concentration . Diabet Med2004;21:388-92.
37.
Valsamakis G., Chetty R., McTernan PG, Al-Daghri NM, Barnett AH, Kumar S.Fasting serum adiponectin concentration is reduced in IndoAsian subjects and related to HDL-cholesterol . Diabetes Obes Metab2003;5:131-5.
38.
Abate N., Chandalia M., Snell PG, Grundy SMAdipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab2002;89:2750-5.
39.
Ridker PM, Rifai N., Rose L., Buring JE, Cook NRComparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New Engl J Med2002;347:1557-65.
40.
Forouhi NG, Sattar N., McKeigue PMRelation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord2001;25: 1327-31.
41.
1. Chandalia M., Cabo-Chan A., Devaraj S., Jialal I., Grundy SM, Abate N.Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab2003; 88:3773-6.
42.
Klerk M., Verhoef P., Clarke R., Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group.MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA2002;288:2023-31.
43.
Chambers JC, Obeid OA, Refsum H. et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet2000;355:523-7.
44.
Wannamethee S., Lowe GD, Whincup PH, Rumley A., Walker M., Lennon L.Physical activity and hemostatic and inflammatory variables in elderly men. Circulation2002 ;105:1785-90.
Lean ME, Han TS, Bush H., Anderson AS, Bradby H., Williams R.Ethnic differences in anthropometric and lifestyle measures related to coronary heart disease risk between south Asian, Italian and general population British women living in the west of Scotland. Int J Obes Relat Metab Disord2001;25:1800-05.
47.
Barnett AH, Grant PJ, Hitman GA et al. on behalf of the Indo-Asian Trial Investigators.Rosiglitazone in type 2 diabetes mellitus: an evaluation in British Indo-Asian patients. Diabet Med2003;20:387-93.
48.
Ammari F., Davies M., Koppiker N., Gregory R., Burden ACThe effect of gliclazide on plasma insulin, intact and 32/33 split proinsulin in south Asian subjects with type 2 diabetes mellitus. Diabet Med1999;16:142-6.
49.
The DECODA study group on behalf of the International Diabetes Epidemiology Group.Cardiovascular risk profile assessment in glucose-intolerant Asian individuals - an evaluation of the World Health Organization two-step strategy: the DECODA study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia). Diabet Med2002;19:549-57.
50.
Diabetes Prevention ProgramResearch Group.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin . N Engl J Med2002;346:393-403.
51.
Pais P., Pogue J., Gerstein H. et al. Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet1996;348:358-63.
52.
McKeigue PM , Marmot MG, Adelstein AM et al. Diet and risk factors for coronary heart disease in Asians in northwest London. Lancet1985;2: 1086-90.
53.
Gupta R., Gupta VP, Ahluwalia NSEducational status, coronary heart disease, and coronary risk factor prevalence in a rural population of India. BMJ1994;309:1332-6.
54.
Diabetes in minority ethnic groups in Scotland.A Report by the National Resource Centre for Ethnic Minority health in collaboration with the Scottish Diabetes Group. 2004 . Health Scotland, Glasgow.
55.
Mukhopadhyay B., Forouhi N., Fisher BM, Kesson C., Sattar N.South Asians have a more rapid deterioration in glycaemic control relative to Europeans: results from follow up in a routine diabetes clinic. Diabet Med (in press).
